Medical Patent News

RSS

AMP congratulates SACGHS on the publication of their DNA patenting report

The Association for Molecular Pathology (AMP) provided comments at the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) meeting on October 8. AMP opposes the patenting of all naturally occurring genetic material and has signed on as a lead plaintiff in the ACLU case challenging Myriad Genetics' patents on the BRCA 1 and BRCA 2 genes. AMP thanked SACGHS for studying how both patents and restrictive licensing limit patient access and potentially reduce the quality of tests.

15 Oct 2009

European Patent Office to grant two intellectual property patents to Athera Biotechnologies

Athera Biotechnologies AB, an atherosclerosis R&D company developing novel products for treatment and prevention of cardiovascular disease (CVD), announced today that the European Patent Office intends to grant two key patents related to the Company's intellectual property on its two pharmaceutical candidates Annexin A5 and PC-mAb.

14 Oct 2009

NASA signs patent license agreement with OxyHeal Medical Systems for hyperbaric chamber technology

NASA has signed a patent license agreement with a California company to improve the medical community's access to hyperbaric chambers used to treat many medical conditions and emergencies. OxyHeal Medical Systems Inc. of National City, Calif., will develop new products based on technologies NASA originally developed for space.

14 Oct 2009

Champions Biotechnology receives U.S. patent for its tubulin inhibitors

Champions Biotechnology, Inc., a drug development company with a preclinical platform able to predict clinical effectiveness, accelerate development and enhance the value of oncology drugs, today announced that the United States Patent and Trademark Office issued a patent on September 29, 2009 for the company's tubulin inhibitors, including its lead compound SG410.

14 Oct 2009

LiveProcess receives patent for its "Networked Emergency Management System"

LiveProcess Corporation, the market leader in web-based emergency preparedness and incident management solutions for hospitals and healthcare organizations, announced today that the U.S. Patent Office (PTO) has issued U.S. Patent No. 7,596,608 to LiveProcess.

14 Oct 2009

Endologix defends patent infringement lawsuit

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has conducted further evaluation of the patent infringement lawsuit filed against the company last week by Cook Medical, and of the patents asserted in the lawsuit.

14 Oct 2009

U.S. Patent and Trademark Office grants patent to Applied Technology Holdings

Applied Technology Holdings, Inc., revealed today that the U.S. Patent and Trademark Office has granted its patent on a system for the gathering and processing of biometric and biomechanical body motion data.

14 Oct 2009

Histostem awarded U.S. patent for isolation of mesenchymal stem cells

Stem Cell Therapy International, Inc. announced that its soon to be subsidiary, Histostem Ltd. of South Korea ("Histostem"), has been awarded U.S. Patent Number 7,582,477 B2, entitled "Method of Isolating and Culturing Mesenchymal Stem Cell Derived from Cryopreserved Umbilical Cord Blood." This patented method is utilized across the company for research, clinical and cosmetic applications.

13 Oct 2009

European Patent Office announces intention to grant patent for Phyton Biotech's methods of producing taxanes

Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing taxanes such as paclitaxel.

13 Oct 2009

BIO disagrees with recommendations of the draft report on Gene Patenting and Licensing

The Biotechnology Industry Organization (BIO) provided comments yesterday to the Secretary’s Advisory Committee on Genetics, Health and Society regarding its draft report on Gene Patenting and Licensing and Their Impact on Patient Access to Genetic Tests. The report makes several recommendations that would restrict the ability to obtain or undermine the enforceability of patents and exclusive licenses with respect to genetic tests.

12 Oct 2009

Cook Medical files lawsuit against Endologix for patent infringement

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, acknowledged today that it has become aware that Cook Medical has filed a lawsuit against Endologix in the United States District Court alleging that Endologix infringes two of Cook's U.S. patents.

9 Oct 2009

GSK and USPTO file joint motion to dismiss litigation over final regulations

GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J. Kappos and the United States Patent and Trademark Office).

9 Oct 2009

Cook claims infringement of its endovascular stent-grafts patents, sues Endologix

In a move aimed at protecting its worldwide market-leading technology for endovascular repair of aortic aneurysms (EVAR), Cook Incorporated has filed a complaint with the U.S. District Court, Southern District of Indiana, against Endologix, Inc. claiming infringement of two critical patents for endovascular stent-grafts.

9 Oct 2009

Valensa initiates licensing patent for the use of the astaxanthin as a dietary supplement

Valensa International (Orlando, FL USA) announced today that it has initiated a broad out licensing effort for University of Illinois patent (US 5,527,533 and its foreign equivalents) for the use of the astaxanthin in eye healthcare dietary supplement applications.

8 Oct 2009

Spectrascience receives Japanese patent for its Optical Biopsy Forceps System and Method of Sampling Tissue

SpectraScience, Inc., a San Diego based medical device company, today announced that it has been awarded Japanese Patent number 4361683 for its Optical Biopsy Forceps System and Method of Sampling Tissue.

8 Oct 2009

Kylin Therapeutics receives notice of allowance for its first U.S. patent application

Officials of Kylin Therapeutics Inc., a leading RNAi company, announced that they have received a notice of allowance from the U.S. Patent and Trademark Office for its first U.S. patent application.

8 Oct 2009

AGA Medical's patent on occlusion devices upheld

AGA Medical Holdings, Inc. today announced that a five-judge panel in the German Federal Patent Court in Munich has upheld the validity of an important AGA Medical patent. The court rejected a lawsuit brought by Occlutech GmbH that contended that AGA Medical's patent did not meet the standards of patentability under German law.

8 Oct 2009

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

AVANIR Pharmaceuticals, Inc. today announced that it has received a “Notice of Allowance” from the United States Patent and Trademark Office (USPTO) announcing that it intends to grant the Company a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia™ well into 2025.

8 Oct 2009

Impax Laboratories settles FLOMAX litigation, to launch generic tamsulosin hydrochloride product

Impax Laboratories, Inc. today announced that it has reached agreement with Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. to settle pending U.S. litigation with regard to US Patent No. 4,703,063 for FLOMAX® (generic name: tamsulosin hydrochloride) capsules through the entry of a consent judgment confirming the validity and infringement of the patent. FLOMAX® is a treatment for the functional symptoms of benign prostatic hyperplasia.

7 Oct 2009

EnWave files a patent application for nutraREV equipment in Canada

EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.

7 Oct 2009

Medical Patent News

AMP congratulates SACGHS on the publication of their DNA patenting report

European Patent Office to grant two intellectual property patents to Athera Biotechnologies

NASA signs patent license agreement with OxyHeal Medical Systems for hyperbaric chamber technology

Champions Biotechnology receives U.S. patent for its tubulin inhibitors

LiveProcess receives patent for its "Networked Emergency Management System"

Endologix defends patent infringement lawsuit

U.S. Patent and Trademark Office grants patent to Applied Technology Holdings

Histostem awarded U.S. patent for isolation of mesenchymal stem cells

European Patent Office announces intention to grant patent for Phyton Biotech's methods of producing taxanes

BIO disagrees with recommendations of the draft report on Gene Patenting and Licensing

Cook Medical files lawsuit against Endologix for patent infringement

GSK and USPTO file joint motion to dismiss litigation over final regulations

Cook claims infringement of its endovascular stent-grafts patents, sues Endologix

Valensa initiates licensing patent for the use of the astaxanthin as a dietary supplement

Spectrascience receives Japanese patent for its Optical Biopsy Forceps System and Method of Sampling Tissue

Kylin Therapeutics receives notice of allowance for its first U.S. patent application

AGA Medical's patent on occlusion devices upheld

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

Impax Laboratories settles FLOMAX litigation, to launch generic tamsulosin hydrochloride product

EnWave files a patent application for nutraREV equipment in Canada

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News